Search for: "Roche v. Roche"
Results 781 - 800
of 929
Sort by Relevance
|
Sort by Date
4 May 2009, 8:10 pm
By Andrew Williams -- Last year, a panel of the Federal Circuit affirmed the International Trade Commission's (ITC's) grant of summary judgment against Amgen in its attempts to block importation of Roche's Micera ® peglylated erythropoietin product. [read post]
1 May 2009, 9:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Tarceva (Erlotinib) – India: Delhi High Court Appellate Bench holds in favour of Cipla against Roche in Tarceva patent litigation; Roche fined for ‘material suppression’ (Spicy IP) (PatLit) (Patent Circle) (Spicy IP) (Patent Circle) (Patent Circle) (GenericsWeb) Lovenox (Enoxaparin) –… [read post]
29 Apr 2009, 3:04 pm
Salud abre patentes de Roche y Glaxo vía licencias de utilidad pública Las concesiones de licencias de utilidad pública son un mecanismo previsto en el artículo 77 de la Ley Federal de Propiedad Industrial. [read post]
29 Apr 2009, 3:04 pm
Salud abre patentes de Roche y Glaxo vía licencias de utilidad pública Las concesiones de licencias de utilidad pública son un mecanismo previsto en el artículo 77 de la Ley Federal de Propiedad Industrial. [read post]
23 Apr 2009, 10:00 pm
(Spicy IP) India: Assessing India’s innovation climate (Biotech Blog) Kenya’s anti-counterfeit legislation, India protest (Afro-IP) Mexico: Pharmaceutical trade marks: the Health Law pitfall for applicants (International Law Office) US: BIO IP Counsels’ Committee: Q Todd Dickinson and E Anthony Figg on patent reform (Patent Docs) US: Amgen VP makes case for longer exclusivity period in follow-on biologics legislation (Patent Docs) Products Cepham –… [read post]
18 Apr 2009, 1:00 am
Matthew Roche (J.D. 2009, Catholic) has published Comment, Son of the Boss and the Troubling Legacy of Colony Inc. v. [read post]
17 Apr 2009, 12:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Kubin ruling extends KSR logic to biotech (Managing IP) (Technology Transfer Tactics) (Patent Docs) (Patent Docs) Evista (Raloxifene) Xigris (Drotrecogin alfa) - Court finds Ariad patent claims in suit v. [read post]
23 Mar 2009, 8:53 am
Cole Schuyler Roche ccole@schuylerroche.com [read post]
23 Mar 2009, 8:53 am
Cole Schuyler Roche ccole@schuylerroche.com [read post]
23 Mar 2009, 8:53 am
Cole Schuyler Roche ccole@schuylerroche.com [read post]
20 Mar 2009, 6:00 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: US: Reps Eshoo, Inslee and Barton introduce Pathway for Biosimilars Act (FDA Law Blog) (Patent Docs) (Patent Baristas) (Patent Baristas) (Law360) US: Reps Waxman, Pallone, Deal and Emerson introduce Promoting Innovation and Access to Life-Saving Medicine Act (Intellectual Property Watch) (IPKat) (Patent Docs) EU: Pharma submissions relating to… [read post]
20 Mar 2009, 2:05 am
" Toner v. [read post]
17 Mar 2009, 3:28 am
Dunn v. [read post]
13 Mar 2009, 6:31 am
And the court remanded for the trial court to consider Roche's preemption defense in light of the holding in Wyeth v. [read post]
4 Mar 2009, 11:00 pm
(Spicy IP) Kenya enacts Biosafety Act 2/2009 regulating activities in GMOs, establishing National Biosafety Authority (Afro-IP) US: BIO meets the press: economic health of the biotech industry; follow-on biologics; patent reform (Patent Docs) (Patent Docs) (Intellectual Property Watch) US: Obama touts generic biologics to lower drug costs (Law360) US: Genentech announces victory in Cabilly re-examination (Patent Docs) US: Federal judge rejects Scruggs family’s bid to reconsider summary… [read post]
2 Mar 2009, 10:28 am
Hoffmann-La Roche Ltd. v. [read post]
26 Feb 2009, 11:38 am
Whilst, on the first question, the Court recalled its much chastised Hoffman La Roche case-law on excessive pricing, it nonetheless whispered that, with a view to establish that a price is unreasonable under Article 82(a) EC, the purpose of the royalty could be taken into account: here, the financing of music creation, through the protection of an adequate remuneration for composers ( § §30-31). [read post]
24 Feb 2009, 7:41 am
Roche (reverse doctrine of equivalents). [read post]
13 Feb 2009, 5:00 am
(Profitability through Simplicity) Patent World SPC round-up ‘Prolonging Patent Protection’ by Marjan Noor (SPC Blog) EU: Commission’s view on paediatric extensions (The SPC Blog) EU: Suing, not suing both attract the Commission’s attention – EU pharma inquiry (PatLit) EU: Life Science marks held confusingly similar: Bayern Innovativ – Bayerische Gesellschaft für Innovation und Wissenstransfer mbH, v Office for… [read post]
12 Feb 2009, 10:42 am
Hoffman-La Roche, Inc., 618 N.W.2d 827, 837 (Neb. 2000); Bish v. [read post]
